| Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1 Z Liang, H Wu, J Xia, Y Li, Y Zhang, K Huang, N Wagar, Y Yoon, HT Cho, ... Biochemical pharmacology 79 (6), 817-824, 2010 | 385 | 2010 |
| Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma S Scala, A Ottaiano, PA Ascierto, M Cavalli, E Simeone, P Giuliano, ... Clinical Cancer Research 11 (5), 1835-1841, 2005 | 381 | 2005 |
| Molecular pathways: targeting the CXCR4–CXCL12 axis—untapped potential in the tumor microenvironment S Scala Clinical cancer research 21 (19), 4278-4285, 2015 | 292 | 2015 |
| Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies PA Ascierto, S Scala, G Castello, A Daponte, E Simeone, A Ottaiano, ... Journal of Clinical Oncology 23 (30), 7660-7668, 2005 | 292 | 2005 |
| P-glycoprotein substrates and antagonists cluster into two distinct groups S Scala, N Akhmed, US Rao, K Paull, LB Lan, B Dickstein, JS Lee, ... Molecular Pharmacology 51 (6), 1024-1033, 1997 | 278 | 1997 |
| Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients A Ottaiano, R Franco, A Aiello Talamanca, G Liguori, F Tatangelo, ... Clinical cancer research 12 (9), 2795-2803, 2006 | 251 | 2006 |
| HCV-related hepatocellular carcinoma: From chronic inflammation to cancer G Castello, S Scala, G Palmieri, SA Curley, F Izzo Clinical immunology 134 (3), 237-250, 2010 | 218 | 2010 |
| Adenovirus-mediated suppression of HMGI (Y) protein synthesis as potential therapy of human malignant neoplasias S Scala, G Portella, M Fedele, G Chiappetta, A Fusco Proceedings of the National Academy of Sciences 97 (8), 4256-4261, 2000 | 189 | 2000 |
| Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion C D’Alterio, S Scala, G Sozzi, L Roz, G Bertolini Seminars in cancer biology 60, 351-361, 2020 | 160 | 2020 |
| Human melanoma metastases express functional CXCR4 S Scala, P Giuliano, PA Ascierto, C Ieranò, R Franco, M Napolitano, ... Clinical cancer research 12 (8), 2427-2433, 2006 | 156 | 2006 |
| Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P‐glycoprotein or MRP overexpression JS Lee, S Scala, Y Matsumoto, B Dickstein, R Robey, Z Zhan, G Altenberg, ... Journal of cellular biochemistry 65 (4), 513-526, 1997 | 149 | 1997 |
| Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate EH Abraham, P Okunieff, S Scala, P Vos, MJS Oosterveld, AY Chen, ... Science 275 (5304), 1324-1326, 1997 | 133 | 1997 |
| Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts M Fedele, MT Berlingieri, S Scala, L Chiariotti, G Viglietto, V Rippel, ... Oncogene 17 (4), 413-418, 1998 | 132 | 1998 |
| Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers: new candidates for checkpoint blockade immunotherapy? P Gargiulo, C Della Pepa, S Berardi, D Califano, S Scala, L Buonaguro, ... Cancer treatment reviews 48, 61-68, 2016 | 129 | 2016 |
| Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells A Ottaiano, A di Palma, M Napolitano, C Pisano, S Pignata, F Tatangelo, ... Cancer Immunology, Immunotherapy 54, 781-791, 2005 | 125 | 2005 |
| Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer M Cioffi, C D’Alterio, R Camerlingo, V Tirino, C Consales, A Riccio, ... Scientific reports 5 (1), 10357, 2015 | 119 | 2015 |
| Detection, monitoring, and management of trastuzumab‐induced left ventricular dysfunction: an actual challenge CG Tocchetti, G Ragone, C Coppola, D Rea, G Piscopo, S Scala, ... European journal of heart failure 14 (2), 130-137, 2012 | 113 | 2012 |
| Prostate cancer detection in the “grey area” of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun’s nomogram, two risk … S Perdona, V Cavadas, G Di Lorenzo, R Damiano, G Chiappetta, ... European urology 59 (1), 81-87, 2011 | 112 | 2011 |
| Critical role of the HMGI (Y) proteins in adipocytic cell growth and differentiation RM Melillo, GM Pierantoni, S Scala, S Battista, M Fedele, A Stella, ... Molecular and cellular biology 21 (7), 2485-2495, 2001 | 111 | 2001 |
| Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer C D'alterio, C Consales, M Polimeno, R Franco, L Cindolo, L Portella, ... Current cancer drug targets 10 (7), 772-781, 2010 | 107 | 2010 |
